$DOCS News

Assessing Doximity (DOCS) Valuation After A Year Of Weak Share Price Performance

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

Doximity's (NYSE:DOCS) Soft Earnings Are Actually Better Than They Appear

Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?

Doximity to Present at the William Blair 46th Annual Growth Stock Conference

5 Revealing Analyst Questions From Doximity’s Q1 Earnings Call

Doximity Leadership Shift And AI Push Reframe Growth And Valuation Outlook

Why Are Doximity (DOCS) Shares Soaring Today

Doximity (DOCS) Q1 CY2026 Deep Dive: AI Investments Accelerate Amid Macro and Policy Headwinds

Why Doximity (DOCS) Shares Are Sliding Today

Another Wall Street analyst slashes Doximity stock price outlook

Assessing Doximity (DOCS) Valuation After A Steep Share Price Decline

Doximity, Inc. 2026 Q4 - Results - Earnings Call Presentation

Barclays Downgrades Doximity (DOCS)

OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?

Down 25.7% in 4 Weeks, Here's Why Doximity (DOCS) Looks Ripe for a Turnaround

Doximity Earnings: Strong AI Signals, But Monetization Still Pending

Goldman Sachs Maintains Neutral on Doximity, Lowers Price Target to $24

Barclays Downgrades Doximity to Equal-Weight, Lowers Price Target to $20

Jefferies Downgrades Doximity (DOCS)